Breadcrumbs Home Investors Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year2025202420232022202120202019201820172016201520142013201220112010 2016-10-19 08:30European Patent granted for BUPIRead more 2016-09-28 08:30Moberg Pharma begins patient enrollment in North America and Europe in two Phase 3 studies of MOB-015 in onychomycosisRead more 2016-08-10 08:30Moberg Pharma announces approvals to start Phase 3 study for MOB-015 in U.S. and CanadaRead more 2016-08-09 08:00Moberg Pharma AB Interim Report January - June 2016Read more 2016-07-08 08:30Moberg Pharma completes acquisition of U.S. OTC brands from Prestige BrandsRead more 2016-07-05 08:30Moberg Pharma announces submission of applications to start Phase 3 studies for MOB-015Read more Pagination First page Previous page … Page 42 Page 43 Page 44 Page 45 Current page 46 Page 47 Page 48 Page 49 Page 50 … Next page Last page Press Releases Data Year2025202420232022202120202019201820172016201520142013201220112010 2014-11-04 08:30Moberg Pharma increases efficiency and reduces costs through expanded partnership with Emerson GroupRead more 2014-10-28 08:30First patient included in phase II study of BUPI, a novel topical formulation for treatment of oral painRead more 2014-09-17 08:00Moberg Pharma announces successful results for MOB-015 in a Phase II study for the treatment of onychomycosisRead more 2014-08-28 08:00Moberg Pharma's head of U.S. operations to resign by end of January 2015Read more 2014-08-13 08:00Moberg Pharma AB (Publ) Interim Report January - June 2014Read more 2014-06-30 08:30Change of number of shares and votes in Moberg PharmaRead more Pagination First page Previous page … Page 42 Page 43 Page 44 Page 45 Current page 46 Page 47 Page 48 Page 49 Page 50 … Next page Last page
